Tech Company Financing Transactions
VenomAid Diagnostics Funding Round
On 1/30/2024, VenomAid Diagnostics landed $1.8 million in funding from Good Ventures and private investors.
Transaction Overview
Company Name
Announced On
1/30/2024
Transaction Type
Venture Equity
Amount
$1,800,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and development efforts.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Kolonnevej 239
Kongens Lyngby, 2800
Denmark
Kongens Lyngby, 2800
Denmark
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
VenomAid is a medtech company at the forefront of revolutionizing snakebite care on a global scale by pioneering affordable diagnostics to reach previously neglected populations. Our resolve to bring about change was born from the urgency to bring snakebite care into the 21st century. Snakebite envenoming remains one of the world's most neglected tropical diseases, affecting millions annually and claiming over 100,000 lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Gert Tomczyk
Chief Executive Officer
Jonas Jürgensen
Chief Scientific Officer
Cecilie Knudsen
Chief Technical Officer
Gina Ross
Co-Founder
Andreas Laustsen-Kiel
Browse more venture capital transactions:
Prev: 1/30/2024: Roofer.com venture capital transaction
Next: 1/30/2024: Alchemist Accelerator venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs